ASPIRIANT, LLC 组合持仓
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001433541
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
Q3 2024 · 291 持仓数 · 申报总市值 $2.61B · 前十大集中度 65.7% · 更新于 2026-10-18
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
换手率: 48.7% · 60 新建 · 125 减仓 · 39 清仓
主动份额(对标 S&P 500): 91.7% · 对比 QQQ: 94.7% — 组合中区别于指数权重的部分(越高越主动) · 排名
估算季度收益 (Q2 2026 → Q3 2026): -0.7% · 对比 SPY -2.8% · 上季市值 $4.05B — 按上季持仓市值以本季涨跌加权估算 · 排名
估算季内收益 (Q3 2026 → 最新收盘): +2.2% · 对比 SPY -0.0% · 最新申报市值 $4.08B — 最新申报持仓按季内至今涨跌加权(仍在变动) · 排名
在 Q3 2024 的 13F 申报中,ASPIRIANT, LLC 披露了 291 个股票持仓,合计申报市值 $2.61B。前十大持仓占申报市值的 65.7%,组合属于集中型。HoldingsHub 将其风格标签归纳为 Mid / Focused / High Turnover。
截至 Q3 2024,最大的披露持仓包括 ACWV($276.41M)、IUSV($274.05M)、VTEB($265.51M)。行业分布上,占比最高的板块为 科技 5.5%, 可选消费 1.2%。较上一季度,板块上主要增配 Other(+0.5 个百分点),同时减配 Technology(-0.6 个百分点)。
与上一季度相比,ASPIRIANT, LLC 新建 60 个仓位、减持 125 个、清仓 39 个,换手率约 48.7%。持仓组合与上季度的重合率约为 85%。
Q3 2024 最大新建仓位为 TDG($2.86M)、PWRD($2.02M)、HOOD($985.33K)。
较上季度清仓的 39 个仓位中,金额最大的是 IVW($998.32K)、IYR($880.29K)、PPA($826.18K)。
以上数据来自该基金的 SEC 13F 申报。13F 需在季度结束后 45 天内提交,仅涵盖 10 万美元以上的多头持仓,不含空头与非 13F 资产类别,因此本页反映的是季末快照,并非基金的实时持仓。
新建仓(Q3 2024)
- TDG TRANSDIGM GROUP INC · $2.86M
- PWRD TCW ETF TRUST · $2.02M
- HOOD ROBINHOOD MKTS INC · $985.33K
- SCHG SCHWAB STRATEGIC TR · $395.64K
- GEV GE VERNOVA INC · $347.29K
- COUR COURSERA INC · $333.38K
- NOW SERVICENOW INC · $308.56K
- UPS UNITED PARCEL SVCS INC · $264.91K
完全清仓(较上季)
- IVW ISHARES TR · 上季市值: $998.32K
- IYR ISHARES U.S. REAL ESTATE ETF · 上季市值: $880.29K
- PPA INVESCO AEROSPACE & DEFENSE ETF · 上季市值: $826.18K
- ISTB ISHARES CORE 1-5Y USD BND · 上季市值: $711.26K
- VIS VANGUARD WORLD FD · 上季市值: $651.09K
- FDN FIRST TR EXCHANGE-TRADED FD · 上季市值: $608.67K
- PPH VANECK PHARMACEUTICAL ETF · 上季市值: $548.88K
- SUSA ISHARES TR · 上季市值: $383.41K
内部人交易(Form 4)
ASPIRIANT, LLC 最新申报的 SEC Form 4 买卖——当该基金对某只股票的持股超过 10% 后,交易须在两个交易日内申报。
该基金暂无 Form 4 申报记录——当其对某只股票的持仓超过 10% 时,买卖将在两个交易日内申报至此。
基金介绍
ASPIRIANT, LLC是一家位于洛杉矶的投资公司,由知名激进投资者Jeffery Ubben创立,专注于通过与企业合作进行长期价值投资。
投资方法
通过积极所有权和与管理层合作,专注于长期价值创造。
资产类别与策略
主要投资于科技、医疗保健和金融服务等领域的公开股票,常采取激进投资立场。
知名激进活动
与McKesson、Cardinal Health和AmerisourceBergen等公司合作,推动运营改进和战略变革。
领导层
由Jeffery Ubben创立,他是一位成功的激进投资者。
官方披露信息可在美国证券交易委员会(SEC)网站上查阅。
| # | 公司 | 股数 | 金额 | 权重 | Allocation | 变化 |
|---|---|---|---|---|---|---|
| 1 |
|
2.41M | $276.41M | 10.61% | 持有 | |
| 2 |
|
2.87M | $274.05M | 10.52% | 持有 | |
| 3 |
|
5.19M | $265.51M | 10.19% | 减持 | |
| 4 |
|
440.13K | $253.88M | 9.74% | 增持 | |
| 5 |
|
968.78K | $191.88M | 7.37% | 持有 | |
| 6 |
|
861.23K | $172.92M | 6.64% | 增持 | |
| 7 |
|
153.21K | $80.84M | 3.10% | 增持 | |
| 8 |
|
304.55K | $70.96M | 2.72% | 减持 | |
| 9 |
|
1.18M | $67.67M | 2.60% | 持有 | |
| 10 |
|
982.85K | $56.43M | 2.17% | 持有 | |
| 11 |
|
553.75K | $43.22M | 1.66% | 增持 | |
| 12 |
|
501.39K | $37.66M | 1.45% | 增持 | |
| 13 |
|
60.45K | $34.68M | 1.33% | 增持 | |
| 14 |
|
698.29K | $29.11M | 1.12% | 减持 | |
| 15 |
|
444.44K | $26.33M | 1.01% | 减持 | |
| 16 |
|
91.54K | $25.92M | 0.99% | 减持 | |
| 17 |
|
708.82K | $22.87M | 0.88% | 减持 | |
| 18 |
|
67.86K | $21.34M | 0.82% | 持有 | |
| 19 |
|
466.30K | $20.52M | 0.79% | 减持 | |
| 20 |
|
324.52K | $20.44M | 0.79% | 持有 | |
| 21 |
|
187.82K | $20.40M | 0.78% | 减持 | |
| 22 |
|
735.21K | $19.86M | 0.76% | 增持 | |
| 23 |
|
45.73K | $19.68M | 0.76% | 持有 | |
| 24 |
|
99.84K | $19.58M | 0.75% | 减持 | |
| 25 |
|
391.05K | $18.28M | 0.70% | 增持 | |
| 26 |
|
89.24K | $15.58M | 0.60% | 减持 | |
| 27 |
|
84.28K | $14.06M | 0.54% | 减持 | |
| 28 |
|
109.38K | $13.78M | 0.53% | 持有 | |
| 29 |
|
79.37K | $13.16M | 0.51% | 减持 | |
| 30 |
|
279.05K | $12.65M | 0.48% | 持有 | |
| 31 |
|
21.46K | $12.59M | 0.48% | 持有 | |
| 32 |
|
47.75K | $11.33M | 0.43% | 增持 | |
| 33 |
|
110.85K | $11.23M | 0.43% | 增持 | |
| 34 |
|
46.77K | $10.33M | 0.40% | 增持 | |
| 35 |
|
131.39K | $10.08M | 0.39% | 减持 | |
| 36 |
|
282.03K | $9.67M | 0.37% | 持有 | |
| 37 |
|
171.75K | $9.55M | 0.37% | 持有 | |
| 38 |
|
104.32K | $9.53M | 0.37% | 持有 | |
| 39 |
|
26.06K | $8.51M | 0.33% | 减持 | |
| 40 |
|
211.22K | $8.04M | 0.31% | 减持 | |
| 41 |
|
145.18K | $7.67M | 0.29% | 增持 | |
| 42 |
|
199.19K | $7.44M | 0.29% | 持有 | |
| 43 |
|
114.22K | $7.41M | 0.28% | 持有 | |
| 44 |
|
43.58K | $7.29M | 0.28% | 增持 | |
| 45 |
|
10 | $6.91M | 0.27% | 持有 | |
| 46 |
|
12.05K | $6.90M | 0.27% | 增持 | |
| 47 |
|
34.72K | $6.59M | 0.25% | 增持 | |
| 48 |
|
194.53K | $6.24M | 0.24% | 增持 | |
| 49 |
|
85.66K | $5.81M | 0.22% | 增持 | |
| 50 |
|
29.86K | $5.56M | 0.21% | 持有 | |
常见问题
What did ASPIRIANT, LLC buy in 2024-Q3?
In its 2024-Q3 13F filing, ASPIRIANT, LLC reported 291 equity positions worth $2.61B in aggregate; its largest disclosed positions were ACWV ($276.41M), IUSV ($274.05M), VTEB ($265.51M).
How large is ASPIRIANT, LLC's portfolio?
ASPIRIANT, LLC reported $2.61B of long equity holdings across 291 positions as of 2024-Q3. Top-10 holdings account for 65.7% of reported value.
What is ASPIRIANT, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.